Black tea polyphenol inhibits CXCL10 production in oncostatin M-stimulated human gingival fibroblasts

International Immunopharmacology

Volumn 11, Issue 6, 2011, Pages 670-674

  Hosokawa, Yoshitaka ^a   Hosokawa, Ikuko ^a   Shindo, Satoru ^a   Ozaki, Kazumi ^a   Nakanishi, Tadashi ^a   Nakae, Hideaki ^a   Matsuo, Takashi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CXCL10; Fibroblasts; Oncostatin M; Theaflavin

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; ONCOSTATIN M; ONCOSTATIN M RECEPTOR BETA; PROTEIN KINASE B; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THEAFLAVIN 3,3' DIGALLATE;

ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA;

BIFLAVONOIDS; CATECHIN; CELLS, CULTURED; CHEMOKINE CXCL10; FIBROBLASTS; FLAVONOIDS; GALLIC ACID; GINGIVA; HUMANS; MAP KINASE KINASE 4; ONCOSTATIN M; ONCOSTATIN M RECEPTOR BETA SUBUNIT; PERIODONTAL DISEASES; PHENOLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; STAT3 TRANSCRIPTION FACTOR; TEA;

EID: 79955824810     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.01.009     Document Type: Article

References (33)

1. Tanaka M, Miyajima A. Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 2003;149:39-52.
2. Korzus E, Nagase H, Rydell R, Travis J. Themitogen-activated protein kinase and JAK- STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem 1997;272:1188-96. (Pubitemid 27034616)
3. Langdon C, Leith J, Smith F, Richards C. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase- 1 production by human synovial fibroblasts in vitro. Arthritis Rheum 1997;40:2139-46. (Pubitemid 28016409)
4. Weiss T, Kvakan H, Kaun C, Zorn G, Speidl W, Pfaffenberger S, et al. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart. J Mol Cell Cardiol 2005;39:545-51. (Pubitemid 41133740)
5. Grenier A, Combaux D, Chastre J, Gougerot-Pocidalo M, Gibert C, Dehoux M, et al. Oncostatin M production by blood and alveolar neutrophils during acute lung injury. Lab Invest 2001;81:133-41. (Pubitemid 32176376)
6. Hurst S, McLoughlin R, Monslow J, Owens S, Morgan L, Fuller G, et al. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol 2002;169:5244-51. (Pubitemid 35217196)
7. Langdon C, Kerr C, Tong L, Richards C. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. J Immunol 2003;170:548-55. (Pubitemid 36026182)
8. Brown T, Lioubin M, Marquardt H. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic anti-proliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. J Immunol 1987;139:2977-83. (Pubitemid 17157467)
9. Grove R, Mazzucco C, Allegretto N, Kiener P, Spitalny G, Radka S, et al. Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells. J Lipid Res 1991;32:1889-97.
10. Sodhi A, Shishodia S, Shrivastava A. Cisplatin-stimulated murine bone marrow-derived macrophages secrete oncostatin M. Immunol Cell Biol 1997;75:492-6. (Pubitemid 27508990)
11. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 1997;40:1096-105. (Pubitemid 27242297)
12. Tamura S, Morikawa Y, Tanaka M, Miyajima A, Senba E. Developmental expression pattern of oncostatin M receptor beta in mice. Mech Dev 2002;115:127-31. (Pubitemid 34615676)
13. Lin S, Chen Y, Kuo M, Li C, Lu H. Measurement of gp130 cytokines oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cytokine 2005;30:160-7. (Pubitemid 40615963)
14. Hosokawa Y, Hosokawa I, Ozaki K, Nakanishi T, Nakae H, Matsuo T. Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts. J Nutr Biochem 2010;21:659-64.
15. Luster A, Unkeless J, Ravetch J. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985;315:672-6. (Pubitemid 15232881)
16. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
17. Loetscher M, Gerber B, Loetscher P, Jones S, Piali L, Clark-Lewis I, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-9.
18. Gemmell E, Carter C, Seymour G. Chemokines in human periodontal disease tissues. Clin Exp Immunol 2001;125:134-41. (Pubitemid 32703376)
19. Garlet G, Martins WJ, Ferreira B, Milanezi C, Silva J. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003;38:210-7. (Pubitemid 37485621)
20. Seymour G. Importance of the host response in the periodontium. J Clin Periodontol 1991;18:421-6.
21. Page R, Offenbacher S, Schroeder H, Seymour G, Kornman K. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 1997;2000(14):216-48. (Pubitemid 127601178)
22. Fujihashi K, Kono Y, Beagley K, Yamamoto M, McGhee J, Mestecky J, et al. Cytokines and periodontal disease: immunopathological role of interleukins for B cell responses in chronic inflamed gingival tissues. J Periodontol 1993;64:400-6.
23. Johnson R, Wood N, Serio F. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 2004;75:37-43. (Pubitemid 38312768)
24. Hosokawa Y, Nakanishi T, Yamaguchi D, Nakae H, Matsuo T. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue. Clin Exp Immunol 2005;139:506-12. (Pubitemid 40333263)
25. Hosokawa Y, Nakanishi T, Yamaguchi D, Takahashi K, Yumoto H, Ozaki K, et al. Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue. Clin Exp Immunol 2002;128:548-54. (Pubitemid 34639319)
26. Kawai T, Eisen-Lev R, Seki M, Eastcott J, Wilson M, Taubman M. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000;164:2102-9. (Pubitemid 30108769)
27. Stashenko P, Gonçalves R, Lipkin B, Ficarelli A, Sasaki H, Campos-Neto A. Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis. Am J Pathol 2007;170:203-13. (Pubitemid 47339200)
28. Leung L, Su Y, Chen R, Zhang Z, Huang Y, Chen Z. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 2001;131: 2248-51. (Pubitemid 32851864)
29. Ukil A, Maity S, Das P. Protection from experimental colitis by theaflavin-3, 3′- digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol 2006;149:121-31. (Pubitemid 44299075)
30. Hosokawa Y, Hosokawa I, Ozaki K, Nakanishi T, Nakae H, Matsuo T. Tea polyphenols inhibit IL-6 production in tumor necrosis factor superfamily 14- stimulated human gingival fibroblasts. Mol Nutr Food Res 2010;54(Suppl 2): S151-8.
31. Ahn H, Xu Y, Davidge S. Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci 2008;82:964-8.
32. Akira K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, et al. Oncostatin M receptor-β mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 2008;82:73-84.
33. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK. Suppression of lipopolysaccharide-induced nuclear factor-.B activity by theaflavin-3, 3′-digallate from black tea and other polyphenols through down-regulation of I.B kinase activity in macrophages. Biochem Pharmacol 2000;59:357-67.